Levels of PTHR1 mRNA expressed in metastases or recurrences of osteosarcoma have also proven much higher than those in primary tumours, conferring more aggressive phenotypes and microenvironments more conducive to malignancy.30 The gene discussed is PTH1R; the disease is osteosarcoma.